These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 31997805)

  • 1. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders.
    Polis B; Samson AO
    Neural Regen Res; 2020 Aug; 15(8):1460-1470. PubMed ID: 31997805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer's Disease.
    Polis B; Gurevich V; Assa M; Samson AO
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice.
    Polis B; Squillario M; Gurevich V; Srikanth KD; Assa M; Samson AO
    Neurochem Res; 2022 May; 47(5):1255-1268. PubMed ID: 35098420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect of branched-chain amino acid metabolism promotes the development of Alzheimer's disease by targeting the mTOR signaling.
    Li H; Ye D; Xie W; Hua F; Yang Y; Wu J; Gu A; Ren Y; Mao K
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched-Chain Amino Acids Are Linked with Alzheimer's Disease-Related Pathology and Cognitive Deficits.
    Siddik MAB; Mullins CA; Kramer A; Shah H; Gannaban RB; Zabet-Moghaddam M; Huebinger RM; Hegde VK; MohanKumar SMJ; MohanKumar PS; Shin AC
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiology and pathogenesis of Alzheimer dementia].
    Kratzsch T; Peters J; Frölich L
    Wien Med Wochenschr; 2002; 152(3-4):72-6. PubMed ID: 11925775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
    Dickson TC; Saunders HL; Vickers JC
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.
    Anthony IC; Norrby KE; Dingwall T; Carnie FW; Millar T; Arango JC; Robertson R; Bell JE
    Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer's disease and diabetes - the common pathogenesis].
    Halmos T; Suba I
    Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
    Madav Y; Wairkar S; Prabhakar B
    Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
    de Paula VJR; Guimarães FM; Diniz BS; Forlenza OV
    Dement Neuropsychol; 2009; 3(3):188-194. PubMed ID: 29213627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.